Viewing Study NCT00496132


Ignite Creation Date: 2025-12-24 @ 9:45 PM
Ignite Modification Date: 2026-01-13 @ 3:23 AM
Study NCT ID: NCT00496132
Status: TERMINATED
Last Update Posted: 2017-07-02
First Post: 2007-07-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Sponsor: Genentech, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Lymphocytic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CLL View
None Leukemia View
None Lymph View